JPWO2018191479A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2018191479A5 JPWO2018191479A5 JP2019555854A JP2019555854A JPWO2018191479A5 JP WO2018191479 A5 JPWO2018191479 A5 JP WO2018191479A5 JP 2019555854 A JP2019555854 A JP 2019555854A JP 2019555854 A JP2019555854 A JP 2019555854A JP WO2018191479 A5 JPWO2018191479 A5 JP WO2018191479A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- amino acid
- acid sequence
- tslp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023080295A JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗ｔｓｌｐ抗体による喘息治療 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762484864P | 2017-04-12 | 2017-04-12 | |
| US62/484,864 | 2017-04-12 | ||
| US201762553477P | 2017-09-01 | 2017-09-01 | |
| US201762553575P | 2017-09-01 | 2017-09-01 | |
| US62/553,575 | 2017-09-01 | ||
| US62/553,477 | 2017-09-01 | ||
| PCT/US2018/027271 WO2018191479A1 (en) | 2017-04-12 | 2018-04-12 | Treatment of asthma with anti-tslp antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080295A Division JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗ｔｓｌｐ抗体による喘息治療 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020516647A JP2020516647A (ja) | 2020-06-11 |
| JP2020516647A5 JP2020516647A5 (zh) | 2021-05-20 |
| JPWO2018191479A5 true JPWO2018191479A5 (zh) | 2022-11-22 |
| JP7330896B2 JP7330896B2 (ja) | 2023-08-22 |
Family
ID=62092313
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019555854A Active JP7330896B2 (ja) | 2017-04-12 | 2018-04-12 | 抗ｔｓｌｐ抗体による喘息治療 |
| JP2023080295A Pending JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗ｔｓｌｐ抗体による喘息治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080295A Pending JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗ｔｓｌｐ抗体による喘息治療 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10828365B2 (zh) |
| EP (1) | EP3609917A1 (zh) |
| JP (2) | JP7330896B2 (zh) |
| KR (2) | KR102666879B1 (zh) |
| CN (1) | CN110573525A (zh) |
| AU (1) | AU2018253118A1 (zh) |
| BR (1) | BR112019021482A2 (zh) |
| CA (1) | CA3059364A1 (zh) |
| CL (1) | CL2019002897A1 (zh) |
| CO (1) | CO2019011462A2 (zh) |
| IL (1) | IL269791B (zh) |
| JO (1) | JOP20190243A1 (zh) |
| MX (1) | MX2019012158A (zh) |
| PE (1) | PE20200484A1 (zh) |
| PH (1) | PH12019502331A1 (zh) |
| SG (1) | SG11201909322VA (zh) |
| TN (1) | TN2019000289A1 (zh) |
| UY (1) | UY37676A (zh) |
| WO (1) | WO2018191479A1 (zh) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20181368A1 (es) * | 2015-09-09 | 2018-08-27 | Novartis Ag | Moleculas de union a linfopoyetina estromal timica (tslp) y metodos de uso de las moleculas |
| EP3981788A4 (en) * | 2019-06-04 | 2023-03-22 | Jiangsu Hengrui Medicine Co., Ltd. | ANTIBODY CAPABLE OF BINDING THYMIC STROMAL LYMPHOPOIETIN AND ITS USE |
| WO2021007533A1 (en) * | 2019-07-11 | 2021-01-14 | Tavotek Biotherapeutics (Hong Kong) Limited | Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling |
| EP4025602A4 (en) * | 2019-09-04 | 2023-12-13 | Biosion, Inc. | TSLP-BINDING ANTIBODIES AND THEIR USES |
| CR20220189A (es) * | 2019-10-28 | 2022-08-19 | Medimmune Ltd | Formulaciones en polvo seco de anticuerpos de unión a linfopoyetina estromal tímica (tslp) y métodos para usarlos. |
| EP4047019A4 (en) * | 2019-12-13 | 2023-11-15 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | ANTI-TSLP ANTIBODIES AND USES THEREOF |
| TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法 |
| EP4103605A1 (en) * | 2020-02-13 | 2022-12-21 | Amgen Inc. | Treatment of atopic dermatitis with anti-tslp antibody |
| KR20220140772A (ko) * | 2020-02-13 | 2022-10-18 | 암젠 인크 | 인간 항-tslp 항체 제형 및 염증성 질환의 치료 방법 |
| IL295511A (en) * | 2020-02-18 | 2022-10-01 | Amgen Inc | Formulations of human anti-tslp antibodies and methods of using them |
| TW202229339A (zh) * | 2020-12-03 | 2022-08-01 | 大陸商江蘇恒瑞醫藥股份有限公司 | 結合胸腺基質淋巴細胞生成素的抗體及其應用 |
| CN113501878B (zh) * | 2021-02-03 | 2022-12-02 | 北京智仁美博生物科技有限公司 | 针对人tslp的多种抗体及其用途 |
| CN114853888B (zh) * | 2021-02-05 | 2023-11-03 | 上海洛启生物医药技术有限公司 | 抗tslp纳米抗体及其应用 |
| EP4302778A1 (en) * | 2021-03-03 | 2024-01-10 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Pharmaceutical composition containing anti-tslp antibody |
| IL307651A (en) * | 2021-04-19 | 2023-12-01 | Medimmune Ltd | Anti-TSLP FAB with improved stability |
| BR112023022041A2 (pt) | 2021-04-23 | 2023-12-26 | Amgen Inc | Anticorpos anti-tslp modificados |
| EP4326766A1 (en) | 2021-04-23 | 2024-02-28 | Amgen Inc. | Anti-tslp antibody compositions and uses thereof |
| CN113683694B (zh) * | 2021-09-03 | 2022-05-13 | 江苏荃信生物医药股份有限公司 | 一种抗人tslp单克隆抗体及其应用 |
| CN117209603B (zh) * | 2021-12-02 | 2024-02-27 | 北京东方百泰生物科技股份有限公司 | 一种抗tslp的单克隆抗体、其抗原结合片段及其应用 |
| US12110324B2 (en) | 2022-07-22 | 2024-10-08 | Flagship Pioneering Innovations Vi, Llc | Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP) |
| TW202426485A (zh) | 2022-10-26 | 2024-07-01 | 美商安進公司 | 抗ｔｓｌｐ抗體組成物及其用途 |
| CN117551195B (zh) * | 2024-01-12 | 2024-04-09 | 杭州畅溪制药有限公司 | 靶向tslp的vhh纳米抗体及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| JP3068180B2 (ja) | 1990-01-12 | 2000-07-24 | アブジェニックス インコーポレイテッド | 異種抗体の生成 |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| DE69637481T2 (de) | 1995-04-27 | 2009-04-09 | Amgen Fremont Inc. | Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8 |
| US7982016B2 (en) * | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| US8359965B2 (en) | 2007-09-17 | 2013-01-29 | Oxford J Craig | Apparatus and method for broad spectrum radiation attenuation |
| TW201018482A (en) | 2008-08-08 | 2010-05-16 | Glaxo Wellcome Mfg Pte Ltd | Novel treatment |
| WO2011056772A1 (en) | 2009-11-04 | 2011-05-12 | Schering Corporation | Engineered anti-tslp antibody |
| AR082163A1 (es) * | 2010-07-15 | 2012-11-14 | Hoffmann La Roche | Anticuerpos especificamente ligantes del tslpr humano y metodos de utilizacion de los mismos |
| US9100245B1 (en) | 2012-02-08 | 2015-08-04 | Amazon Technologies, Inc. | Identifying protected media files |
| US9306926B2 (en) | 2013-03-15 | 2016-04-05 | Brian A. Truong | User authentication using unique hidden identifiers |
| KR20160068802A (ko) * | 2013-10-23 | 2016-06-15 | 제넨테크, 인크. | 호산구성 장애를 진단 및 치료하는 방법 |
| CN107106679B (zh) * | 2014-08-08 | 2022-07-26 | 艾利妥 | 抗trem2抗体及其使用方法 |
| RU2017134274A (ru) * | 2015-03-11 | 2019-04-03 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Связывающие tslp белки |
| MY186352A (en) | 2015-09-09 | 2021-07-15 | Novartis Ag | Thymic stromal lymphopoietin (tslp)-binding antibodies and methods of using the antibodies |
-
2017
- 2017-06-16 JO JOP/2019/0243A patent/JOP20190243A1/ar unknown
-
2018
- 2018-04-12 CN CN201880026131.3A patent/CN110573525A/zh active Pending
- 2018-04-12 US US15/951,602 patent/US10828365B2/en active Active
- 2018-04-12 KR KR1020197033043A patent/KR102666879B1/ko active IP Right Grant
- 2018-04-12 WO PCT/US2018/027271 patent/WO2018191479A1/en unknown
- 2018-04-12 UY UY0001037676A patent/UY37676A/es unknown
- 2018-04-12 AU AU2018253118A patent/AU2018253118A1/en active Pending
- 2018-04-12 JP JP2019555854A patent/JP7330896B2/ja active Active
- 2018-04-12 MX MX2019012158A patent/MX2019012158A/es unknown
- 2018-04-12 CA CA3059364A patent/CA3059364A1/en active Pending
- 2018-04-12 PE PE2019002026A patent/PE20200484A1/es unknown
- 2018-04-12 BR BR112019021482-8A patent/BR112019021482A2/pt unknown
- 2018-04-12 TN TNP/2019/000289A patent/TN2019000289A1/en unknown
- 2018-04-12 IL IL269791A patent/IL269791B/en unknown
- 2018-04-12 EP EP18721605.6A patent/EP3609917A1/en active Pending
- 2018-04-12 SG SG11201909322V patent/SG11201909322VA/en unknown
- 2018-04-12 KR KR1020247015858A patent/KR20240070727A/ko not_active Application Discontinuation
-
2019
- 2019-10-11 PH PH12019502331A patent/PH12019502331A1/en unknown
- 2019-10-11 CL CL2019002897A patent/CL2019002897A1/es unknown
- 2019-10-16 CO CO2019011462A patent/CO2019011462A2/es unknown
-
2020
- 2020-11-09 US US17/093,387 patent/US20210052726A1/en active Pending
-
2023
- 2023-05-15 JP JP2023080295A patent/JP2023099233A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516647A5 (zh) | ||
| JPWO2018191479A5 (zh) | ||
| JP7330896B2 (ja) | 抗ｔｓｌｐ抗体による喘息治療 | |
| Md Yusof et al. | Targeting interleukin-6 in rheumatoid arthritis | |
| Menzella et al. | Tailored therapy for severe asthma | |
| AU2010248935B2 (en) | Methods and compositions for treating lupus | |
| JP2022512722A (ja) | 抗ｃｄ３８抗体の皮下投与を提供する方法 | |
| JP2020536097A5 (zh) | ||
| WO2017064615A1 (en) | Use of c5 inhibitors in transplant associated microangiopathy | |
| JP2021193121A (ja) | Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法 | |
| Amini-Vaughan et al. | Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer | |
| JP2020520912A (ja) | 抗ｇｉｔｒアゴニスト抗体での癌の処置 | |
| JP2024502471A (ja) | ピーナッツアレルギーを治療するための方法およびｉｌ－４ｒアンタゴニストを投与することによってピーナッツアレルゲン特異的免疫療法を増強する方法 | |
| US20240287170A1 (en) | Methods for treating systemic sclerosis | |
| JP2018533588A (ja) | 治療パラダイム | |
| US20230398229A1 (en) | Antibody drug conjugates comprising sting agonists, combinations and methods of use | |
| WO2021213523A1 (zh) | 抗pd-1抗体和抗ctla-4抗体的组合在预防或治疗癌症中的用途 | |
| CN115814076A (zh) | 抗人vegf抗体与化药联用在制备治疗卵巢癌的药物中的应用 | |
| WO2024153182A1 (zh) | 抗pvrig/抗tigit双特异性抗体在治疗恶性肿瘤中的用途 | |
| CN113993543B (zh) | 使用抗cd38抗体的组合疗法 | |
| TW202430575A (zh) | 抗ｐｖｒｉｇ／抗ｔｉｇｉｔ雙特異性抗體在治療惡性腫瘤中的用途 | |
| JP2023505215A (ja) | Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法 | |
| JP2002521491A (ja) | 関節リウマチまたは皮膚疾患の処置に使用するためのｃｄ２５結合分子 | |
| JPWO2019231983A5 (zh) | ||
| JP2023506779A (ja) | 慢性移植片対宿主病の処置用抗体 |